
Cigna Group
CI338.820USD
+6.900+2.07%
Handelsschluss 04/03, 16:00(ET)Kurse um 15 Minuten verzögert
92.77BMarktkapitalisierung
27.01KGV TTM
mehr Informationen über Cigna Group Unternehmen
The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. The Company’s portfolio of offerings solves diverse challenges across the healthcare system. Evernorth Health Services includes a range of independent and coordinated health solutions and capabilities designed to enable the healthcare system to help people live richer, healthier lives. Health plans, employers, governmental organizations and health care providers partner with Evernorth Health Services to solve their challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. Cigna Healthcare includes the United States healthcare and international health businesses, which provide comprehensive medical and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI) and the Company's run-off operations.
Unternehmensinformationen
Unternehmens-codeCI
Name des UnternehmensCigna Group
IPO-datumApr 01, 1982
Gegründet am2018
CEOMr. Eric P. Palmer
Anzahl der mitarbeiter73500
WertpapierartOrdinary Share
GeschäftsjahresendeApr 01
Addresse- -
Stadt- -
BörseNYSE Consolidated
Land- -
Postleitzahl- -
Telefon- -
Website- -
Unternehmens-codeCI
IPO-datumApr 01, 1982
Gegründet am2018
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David M. Cordani, CPA
Mr. David M. Cordani, CPA
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
667.15K
-3.82%
Mr. Brian C. Evanko
Mr. Brian C. Evanko
President, Chief Operating Officer
President, Chief Operating Officer
64.33K
+18.95%
Ms. Donna F. Zarcone, CPA
Ms. Donna F. Zarcone, CPA
Independent Director
Independent Director
26.10K
--
Mr. Eric C. Wiseman
Mr. Eric C. Wiseman
Lead Independent Director
Lead Independent Director
22.52K
--
Ms. Noelle K. Eder
Ms. Noelle K. Eder
Executive Vice President, Global Chief Information Officer
Executive Vice President, Global Chief Information Officer
21.71K
-31.41%
Dr. David J. Brailer, M.D., Ph.D.
Dr. David J. Brailer, M.D., Ph.D.
Executive Vice President, Chief Health Officer and Chief Transformation Officer
Executive Vice President, Chief Health Officer and Chief Transformation Officer
17.82K
+97.02%
Dr. Mark B. Mcclellan, M.D., Ph.D.
Dr. Mark B. Mcclellan, M.D., Ph.D.
Independent Director
Independent Director
5.47K
--
Maj. Gen. (Retd.) Elder Granger, M.D.
Maj. Gen. (Retd.) Elder Granger, M.D.
Independent Director
Independent Director
5.47K
--
Ms. Kathleen M. Mazzarella
Ms. Kathleen M. Mazzarella
Independent Director
Independent Director
5.47K
--
Ms. Kimberly A. Ross
Ms. Kimberly A. Ross
Independent Director
Independent Director
3.87K
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David M. Cordani, CPA
Mr. David M. Cordani, CPA
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
667.15K
-3.82%
Mr. Brian C. Evanko
Mr. Brian C. Evanko
President, Chief Operating Officer
President, Chief Operating Officer
64.33K
+18.95%
Ms. Donna F. Zarcone, CPA
Ms. Donna F. Zarcone, CPA
Independent Director
Independent Director
26.10K
--
Mr. Eric C. Wiseman
Mr. Eric C. Wiseman
Lead Independent Director
Lead Independent Director
22.52K
--
Ms. Noelle K. Eder
Ms. Noelle K. Eder
Executive Vice President, Global Chief Information Officer
Executive Vice President, Global Chief Information Officer
21.71K
-31.41%
Dr. David J. Brailer, M.D., Ph.D.
Dr. David J. Brailer, M.D., Ph.D.
Executive Vice President, Chief Health Officer and Chief Transformation Officer
Executive Vice President, Chief Health Officer and Chief Transformation Officer
17.82K
+97.02%
Umsatzaufteilung
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Pharmacy revenues
185.36B
0.00%
Network revenues
105.34B
0.00%
Home delivery and specialty revenues
72.48B
0.00%
Fees and other revenues
14.79B
0.00%
Other revenues
11.54B
0.00%
Intercompany eliminations
-4.06B
0.00%

Keine Daten
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Pharmacy revenues
185.36B
0.00%
Network revenues
105.34B
0.00%
Home delivery and specialty revenues
72.48B
0.00%
Fees and other revenues
14.79B
0.00%
Other revenues
11.54B
0.00%
Intercompany eliminations
-4.06B
0.00%
Aktionäre
Update-Zeit: Fri, Feb 21
Update-Zeit: Fri, Feb 21
Aktionärsstatistik
Art
Aktionärsstatistik
Aktionäre
Anteil
The Vanguard Group, Inc.
9.58%
BlackRock Institutional Trust Company, N.A.
4.94%
State Street Global Advisors (US)
4.69%
MFS Investment Management
4.14%
T. Rowe Price Associates, Inc.
3.90%
Other
72.75%
Aktionärsstatistik
Aktionäre
Anteil
The Vanguard Group, Inc.
9.58%
BlackRock Institutional Trust Company, N.A.
4.94%
State Street Global Advisors (US)
4.69%
MFS Investment Management
4.14%
T. Rowe Price Associates, Inc.
3.90%
Other
72.75%
Art
Aktionäre
Anteil
Investment Advisor
41.89%
Investment Advisor/Hedge Fund
40.22%
Pension Fund
2.45%
Research Firm
2.37%
Hedge Fund
2.01%
Bank and Trust
1.68%
Sovereign Wealth Fund
1.27%
Corporation
1.18%
Individual Investor
0.39%
Other
6.54%
Institutionelle Beteiligung
Update-Zeit: Sun, Jan 19
Update-Zeit: Sun, Jan 19
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q1
2892
255.58M
94.27%
-3.17M
2024Q4
2993
255.45M
93.32%
-4.13M
2024Q3
2931
253.73M
90.72%
-10.03M
2024Q2
2910
254.99M
91.23%
-15.89M
2024Q1
2865
261.02M
89.38%
-14.30M
2023Q4
2815
267.28M
91.36%
-8.83M
2023Q3
2725
267.63M
91.08%
-13.20M
2023Q2
2737
270.13M
91.28%
-8.82M
2023Q1
2710
268.83M
90.70%
-14.56M
2022Q4
2688
273.82M
91.52%
-15.33M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
25.98M
9.58%
+22.81K
+0.09%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
13.39M
4.94%
+8.80K
+0.07%
Dec 31, 2024
State Street Global Advisors (US)
12.72M
4.69%
-105.73K
-0.82%
Dec 31, 2024
MFS Investment Management
11.23M
4.14%
+489.58K
+4.56%
Dec 31, 2024
T. Rowe Price Associates, Inc.
10.56M
3.9%
-1.12M
-9.58%
Dec 31, 2024
Fidelity Management & Research Company LLC
9.98M
3.68%
-1.68M
-14.38%
Dec 31, 2024
Dodge & Cox
8.77M
3.24%
-16.81K
-0.19%
Dec 31, 2024
Sanders Capital, LLC
8.05M
2.97%
+154.42K
+1.95%
Dec 31, 2024
Geode Capital Management, L.L.C.
5.96M
2.2%
+101.74K
+1.74%
Dec 31, 2024
GQG Partners, LLC
4.02M
1.48%
+737.10K
+22.44%
Dec 31, 2024
Mehr Anzeigen
Verbundene ETFs
Update-Zeit: Wed, Apr 2
Update-Zeit: Wed, Apr 2
Name
Anteil
iShares U.S. Healthcare Providers ETF
11.15%
First Trust Large Cap US Equity Select ETF
3.93%
Monarch Dividend Plus Index ETF
3.5%
VictoryShares Free Cash Flow ETF
3.23%
Davis Select US Equity ETF
2.89%
Simplify Health Care ETF
2.76%
Fidelity Blue Chip Value ETF
2.7%
Hennessy Stance ESG ETF
2.61%
VictoryShares US Multi-Factor Minimum Vol ETF
2.38%
Brandes US Value ETF
2.25%
Mehr Anzeigen
iShares U.S. Healthcare Providers ETF
Anteil11.15%
First Trust Large Cap US Equity Select ETF
Anteil3.93%
Monarch Dividend Plus Index ETF
Anteil3.5%
VictoryShares Free Cash Flow ETF
Anteil3.23%
Davis Select US Equity ETF
Anteil2.89%
Simplify Health Care ETF
Anteil2.76%
Fidelity Blue Chip Value ETF
Anteil2.7%
Hennessy Stance ESG ETF
Anteil2.61%
VictoryShares US Multi-Factor Minimum Vol ETF
Anteil2.38%
Brandes US Value ETF
Anteil2.25%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
5.74B
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Jan 30, 2025
CI.NB Interim Cash Dividend of gross USD 1.51 paid on Mar 20, 2025 going ex on Mar 05, 2025 with reinvestment option
Mar 05, 2025
Mar 20, 2025
Mar 05, 2025
Oct 23, 2024
CI.NB Final Cash Dividend of gross USD 1.4 paid on Dec 19, 2024 going ex on Dec 04, 2024
Dec 04, 2024
Dec 19, 2024
Dec 04, 2024
Jul 24, 2024
CI.NB Interim Cash Dividend of gross USD 1.4 paid on Sep 19, 2024 going ex on Sep 04, 2024 with reinvestment option
Sep 04, 2024
Sep 19, 2024
Sep 04, 2024
Apr 24, 2024
CI.NB Interim Cash Dividend of gross USD 1.4 paid on Jun 20, 2024 going ex on Jun 04, 2024 with reinvestment option
Jun 04, 2024
Jun 20, 2024
Jun 04, 2024
Feb 02, 2024
CI.NB Interim Cash Dividend of gross USD 1.4 paid on Mar 21, 2024 going ex on Mar 05, 2024 with reinvestment option
Mar 06, 2024
Mar 21, 2024
Mar 05, 2024
Oct 25, 2023
CI.NB Final Cash Dividend of gross USD 1.23 paid on Dec 21, 2023 going ex on Dec 05, 2023
Dec 06, 2023
Dec 21, 2023
Dec 05, 2023
Jul 26, 2023
CI.NB Interim Cash Dividend of gross USD 1.23 paid on Sep 21, 2023 going ex on Sep 05, 2023 with reinvestment option
Sep 06, 2023
Sep 21, 2023
Sep 05, 2023
Apr 26, 2023
CI.NB Interim Cash Dividend of gross USD 1.23 paid on Jun 22, 2023 going ex on Jun 06, 2023 with reinvestment option
Jun 07, 2023
Jun 22, 2023
Jun 06, 2023
Feb 03, 2023
CI.NB Interim Cash Dividend of gross USD 1.23 paid on Mar 23, 2023 going ex on Mar 07, 2023 with reinvestment option
Mar 08, 2023
Mar 23, 2023
Mar 07, 2023
Oct 26, 2022
CI.NB Final Cash Dividend of gross USD 1.12 paid on Dec 21, 2022 going ex on Dec 05, 2022
Dec 06, 2022
Dec 21, 2022
Dec 05, 2022
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis

Keine Daten
Datum
Art
Verhältnis

Keine Daten